Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers

Cancer Investigation

Volumn 15, Issue 6, 1997, Pages 513-521

  Hiscox, Stephen E ^a   Hallett, Maurice B ^a   Puntis, Malcom C A ^a   Nakamura, Toshikazu ^b   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

C met; Colon cancer; Hepatocyte growth factor

Indexed keywords

LIGAND; MESSENGER RNA; PROTEIN; PROTEIN TYROSINE KINASE; SCATTER FACTOR;

ARTICLE; CANCER INVASION; CELL MOTILITY; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METASTASIS; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR UPREGULATION;

EID: 0031470998     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909709047592     Document Type: Article

References (56)

1. Cooper CS, Park M, Blair DG, et al: Molecular cloning of a new transforming gene from a chemically-transformed human cell line. Nature 311:29-33, 1984.
2. Bottaro DP, Rubin JS, Faletto DL. et al: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802-804, 1991.
3. Jung W, Castren E, Odenthal M: Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol 126:485-494, 1994.
4. Giordano S, Ponzetto C, Di Renzo MF, et al: Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 339:155-156, 1989.
5. Giordano S, Di Renzo MF, Narsimhan R, et al: Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 4:1383-1388, 1989.
6. Tempest PR, Cooper CS Major GN, et al: Structure of the met protein and variation of met protein kinase activity among human tumor cell lines. Br J Cancer 58:3-7, 1988.
7. Park M, Dean M, Kaul K: Sequence of met protooncogene cDNA has features characteristic of the tyrosine kinase family of growth factor receptors. Proc Natl Acad Sci USA 84: 6379-6383, 1987.
8. Gonzatti-aces M, Seth A, Park M, et al: Characterization of the TPR-MET oncogene p65 and the met protooncogene p140 protein tyrosine kinases. Proc Natl Acad Sci USA 85:21-25, 1988.
9. Naldini L, Vigna E, Narshiman RP, et al: Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-met . Oncogene 6:501-504, 1991.
10. Prat M, Narsimhan PR, Crepaldi T, et al: The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 49:323-328, 1991.
11. Di Renzo MF, Olivero M, Ferro S, et al: Overexpression of the c-met /HGF receptor gene in human thyroid cancers. Oncogene 7:2549-2553, 1992.
12. Di Renzo MF, Poulsom R, Olivero M, et al: Expression of the met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55:1129-1138, 1995.
13. Ebert M, Yokoyama M, Friess H, et al: Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 54:5775-5778, 1994.
14. Nakamura T, Nawa K, Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122:1450-1459, 1984.
15. Nakamura T, Teramoto H, Ichihara A: Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary culatures. Proc Natl Acad Sci USA 86:6489-6493, 1986.
16. Stoker M, Perryman M: An epithelial scatter factor released by embryo fibrobasts. J Cell C Sci 77:209-223, 1985.
17. Gherardi E, Stoker M: Hepatocytes and scatter factor. Nature 346:228, 1990 (letter).
18. Weidner KM, Behrens J, Vandekerckhove J, et al: Scatter factor: Molecular characteristics and the effect on the invasiveness of epithelial cells. J Cell Biol 111:2097-2108, 1990.
19. Weidner KM, Akaki N, Hartmann G, et al: Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88:7001-7005, 1991.
20. Stoker M, Gherardi E, Perryman M, et al: Scatter factor is a fibrobast-derived modulator of epithelial cell motility. Nature 327:239-242, 1987.
21. Noji S, Tashiro K, Koyama E, et al: Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 173:42-47, 1990.
22. Shima N, Itagaki Y, Nagao M, et al: A fibroblast-derived tumor cytotoxic factor/F-TCF (Hepatocyte growth factor/HGF) has multiple functions in vitro. Cell Biol Int Rep 15:379-408, 1991.
23. Yoshinaga Y, Fujita S, Gotoh M, et al: Human lung-cancer cell line producing hepatocyte growth factor/scatter factor. Jpn J Cancer Res 83:1257-1261, 1992.
24. Jiang, WG, Lloyds D, Puntis, et al: Regulation of spreading and growth of human colon cancer cells by hepatocyte growth factor. Clin Exp Metast 11:235-242, ,1993.
25. Shibamoto S, Hayakawa M, Hori T: Hepatocyte growth factor and transforming growth factor-( stimulate both cell growth and migration of human gastric adenocarcinoma cells. Cell Struc Funct 17:185-190, 1992.
26. Bussolino F, Di Renzo MF, Ziche M: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629-641, 1992.
27. Rosen EM, Meromsky L, Setter E, et al: Purified scatter factor stimulates epithelial and vascular endothelial cell migration. Proc Soc Exp Biol Med 195:34-43, 1990.
28. Nagaike M, Hirao S, Tajima H, et al: Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem 266:22781-22784, 1991.
29. Comoglio PM, Di Renzo MF, Naldini L: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biochem 17A:232-235, 1993.
30. Grant DS, Kleinman HK, Goldberg ID: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90:1937-1941, 1993.
31. Jiang, WG, Hiscox S, Hallett MB, et al: Inhibition of hepatocyte growth factor/scatter factor induced motility and invasion of human cancer cells by gamma linolenic acid. Br J Cancer 71:744-752, 1995.
32. Lindroos PM, Zamegar R, Michalopoulos GK: Hepatocyte growth factor (hepatopoietin A) rapidly increase in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 13:743-749, 1991.
33. Gohda E, Tsubouch H, Nakayama H, et al: Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81:414-419, 1988.
34. Taniguchi T, Toi M, Inada K, et al: Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1:1031-1034, 1995.
35. Donaldson GA, Welch JP: Management of cancer of the colon. Surg Clin North Am 54:713-730, 1974.
36. Eisenberg B, De Cosse JJ, Harford F, et al: Carcinoma of the colon and rectum - The natural history reviewed in 1704 patients. Cancer 49:1131-1134, 1982.
37. Allen-Mersh TG: Colorectal liver metastases. J Roy Soc Med 82:2-3, 1989.
38. August DA, Ottow RT, Sugarbaker PH: Clinical perspective of human colorectal cancer metastases. Cancer Metast Rev 3:303-324, 1984.
39. Schiffman E: Motility as a principal requirement for metastasis. Cancer Invest 8: 673-674, 1990.
40. Higuchi O, Mizuno K, Vande Woude GF, et al: Expression of c-met proto-oncogene in COS cells induces the signal transducing high affinity receptor for hepatocyte growth factor. FEBS Lett 301:282-286, 1992.
41. Nakamura T, Nishizawa T, Hagiya M, et al: Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443, 1989.
42. Chonmczynski P, Sacchi N: A single step method of RNA isolation by acid guanidimium thiosulphate-phenol-chloroform extraction. Analyt Biochem 162:156-159, 1987.
43. Joseph A, Weiss GH, Jin L. et al: Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst 87:372-377, 1995.
44. Pisters LL, Troncoso P, Zhau HE, et al: c-met proto-oncogene expression in benign and malignant human prostrate tissues. J Urol 154:293-298, 1995.
45. Humphrey PA, Zhu X, Zarnegar R, et al: Hepatocyte growth factor and its receptor (c-met ) in prostatic carcinoma. Am J Pathol 147:386-396, 1995.
46. Giordano S, Zhen Z, Medico E, et al: Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human met protooncogene. Proc Natl Acad Sci USA 90:649-653, 1993.
47. Rong S, Bodescot M, Blair D, et al: Tumourigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 12:5152-5158, 1992.
48. Liu C, Park M, Tsao MS: Overexpression of c-met protooncogene but not epidermal growth factor receptor or c-erbb-2 in primary human colorectal carcinomas. Oncogene 7:181-185, 1992.
49. Shiota G, Okano J, Kawasaki H, et al: Serum hepatocyte growth factor levels in liver diseases: Clinical implications. Hepatology 21:106-112, 1995.
50. Nakamura S, Gohda E, Matsuo Y, et al: Significant amounts of hepatocyte growth factor detected in blood and bone marrow plasma of leukaemia patients. Br J Haematol 87:640-642, 1994.
51. Abulafi AM, Williams NS: Local recurrence of colorectal cancer: The problem, the mechanisms, management and adjuvant therapy. Br J Surg 81:7-19, 1994.
52. Goligher JC: Treatment of carconma of the colon. In: Surgery of the Anus, Rectum and Colon, 5th ed. London, Bailliere Tindall, 1984, pp 549-550.
53. Jass JR, Love SB, Northover JMA: A new prognostic classification in rectal cancer. Lancet 1:1303-1306, 1987.
54. Nakamori S, Ota DM, Cleary KR, et al: MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 106:353-364, 1994.
55. Remvikos Y, Tomiaga O, Hammel P: Increased p53 protein content of colorectal tumors correlates with poor survival. Br J Cancer 6:758-764, 1992.
56. Comoglio PM: Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. Experientia Supplimenta 65:131-165, 1993.